Analysis

Carnival Corporation to report Q4 earnings on Dec. 19. Here’s what to expect

When Carnival Corporation (NYSE: CCL) reports its fourth-quarter results on Friday, investors will be closely watching demand trends, pricing, and cost discipline,

General Mills (GIS) aims to generate double-digit sales growth from new products in FY2026

Shares of General Mills, Inc. (NYSE: GIS) gained over 2% on Wednesday after the company posted better-than-expected earnings results for the second

Paychex expected to report higher revenue and earnings for Q2 FY26

Paychex, Inc. (NASDAQ: PAYX), a leading provider of human capital management solutions, is undergoing an AI-driven transformation that enhances both its internal

Interviews

AlphaStreet's dedicated Earnings Call section is your one-source destination for all publicly listed earnings conference calls. Listen to CEOs/CFOs discuss their company's earnings reports while Wall Street Analysts ask (or grill) with their hard hitting questions.

Most Read

Infographic: How Lennar (LEN) performed in Q4 2025

Lennar Corporation (NYSE: LEN) reported total revenues of $9.4 billion for the fourth quarter of 2025, compared to $9.9 billion reported in the same period a year ago. Net earnings

December 17, 2025

Paychex expected to report higher revenue and earnings for Q2 FY26

Paychex, Inc. (NASDAQ: PAYX), a leading provider of human capital management solutions, is undergoing an AI-driven transformation that enhances both its internal operations and client-facing services. Entering fiscal 2026, the

December 16, 2025

Signet Jewelers (SIG): A look at the progress made on Grow Brand Love

Shares of Signet Jewelers Limited (NYSE: SIG) fell over 3% on Tuesday. The stock has gained 3% year-to-date. The jewelry retailer delivered strong results for the third quarter of 2026,

December 16, 2025

Research Summary

SentinelOne, Inc. (NYSE: S) Research Summary

SentinelOne, Inc. (NYSE: S) is a leading cybersecurity company that offers advanced threat protection

Ocean Biomedical (NASDAQ: OCEA) Research Summary

Ocean Biomedical, Inc. (NASDAQ: OCEA) is a preclinical biotech company focused on moving new

Viewing Highlight
Loading...
Highlight
Close
Top